Confidential mandate

North America Finance Performance Recovery Director

Planned Hiring / New

North America Finance Performance Recovery Director mandate in Toronto, Canada

Confidential North America Finance Performance Recovery Director in Toronto, Canada, reporting to the Group Chief Financial Officer. Interim Regional & Global Finance Leadership appointment at Director level, a 7-month mandate horizon; five days a week.

The mandate

An interim director will cover a North America regional leadership gap and establish robust performance, cash and corrective-action reporting. The appointee must establish decision truth while maintaining country and functional authority.

The first ten working days will produce a risk-ranked driver bridge, cash view, forecast-bias analysis and recovery ownership map. Temporary decisions include review sequence, analytical standards, recovery-resource allocation and escalation under documented delegation. Unsupported performance submissions may be returned for evidence.

The first quarter will challenge the largest gaps and establish leading indicators linked to operating actions. Months four and five will prove recovery through results rather than revised targets. The director cannot alter commercial commitments, accounting policy, bank authority, statutory representations or permanent organisation.

Each recovery action will retain its baseline, owner, financial mechanism and disconfirming indicator. Actual cash, margin and volume outcomes will be compared with the promised route, separating actions that worked late from those that never worked. Material misses require an explicit continue, redesign or stop decision.

Months six and seven focus on transition. The permanent successor and deputy must independently lead a full performance and cash review, reproduce baseline-to-outcome bridges, decide the next recovery sequence and explain residual exposure to the accountable forum. Only then is handover accepted.

The interim leader will leave a decision log, bias history, unresolved actions and 90-day successor agenda. Extension cannot add a new transformation remit.

The exit review will sample one market miss, one cash variance and one contested regional decision. The successor must trace each from original evidence to action and explain the remaining risk to the sponsor. Any reliance on undocumented interim judgement is converted into an owned action before acceptance.

The handover record will distinguish unresolved execution from assumptions invalidated by external change. It will retain rejected options, temporary judgements and leading indicators so the incoming leader can challenge the next forecast without reconstructing history. Market executives will confirm their continuing actions directly to the successor.

Acceptance will be witnessed by the accountable sponsor and recorded against the defined review outputs. If the successor needs the interim director to explain core bridges or obtain routine owner responses, handover remains incomplete. The remedy is targeted transfer, not automatic extension.

What you will own

  • Reconstruct regional performance through price, volume, mix, currency, timing and one-off bridges.
  • Establish a cash and working-capital view tied to accountable operating actions.
  • Return unsupported forecasts and set temporary recovery priorities within delegation.
  • Identify systematic bias and prevent target revision from being reported as recovery.
  • Install leading indicators and consequence-led escalation.
  • Prove corrective actions against original baselines.
  • Prepare successor and deputy through shadow and reverse-shadow reviews.
  • Complete an independently led acceptance cycle.

Candidate qualifications

  • Demonstrate interim regional finance performance recovery.
  • Show a narrative overturned by driver and cash evidence.
  • Provide a case where revised targets concealed failure to recover.
  • Evidence temporary authority used without taking commercial or statutory ownership.
  • Bring strong forecast-bias and working-capital judgement.
  • Describe live successor acceptance with residual exposure intact.

Working terms and boundaries

  • Seven months at five days a week includes scheduled cross-border travel.
  • Delegation covers analytical standards, review sequence and recovery resources.
  • Commercial commitments, policy, bank authority, statutory representation and permanent organisation are excluded.
  • Handover requires independent successor and deputy performance through a complete review.
  • Any extension is capped at four weeks and solely supports transfer.

Application

Applications for this mandate are received in one way only: through the India Board Terminal's application process. It is automated end to end. Your Executive Passport travels to the mandate holder in its confidential form, your answers to the three questions below are read before anything else in your file, and every stage that follows is recorded on your applications page.

There is no address to write to and no intermediary to call. The mandate holder reads what the Terminal delivers and nothing else, which is what keeps the process the same for every applicant and keeps your name out of it until you release it. Applications close on 10 October 2026. Mandate reference RHF-INT-2026-TOR-00.

More seats like this one

Every live mandate, by seat →

This mandate is confidential. The client is named only under a mutual NDA, and your own record is never listed, sold or shown to a company under your name until you release it for this specific mandate.